Arbutus Biopharma Corp ETF Holding It
Arbutus Biopharma Corp (ABUS). 7 retained portfolio positions. Missing dates and values remain unreported.
- BBC: Fund Virtus Biotech Clinical Trials Etf; Weight 0.66%; Value (USD) $246.12K; Added / first observed 2022-01-31.
- GERM: Fund ETFMG Treatments Testing and Advancements ETF; Weight 0.83%; Value (USD) $106.30K; Added / first observed 2020-09-30.
- GSSC: Fund Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF; Weight 0.04%; Value (USD) $382.00K; Added / first observed 2024-08-31.
- IBBJ: Fund Defiance Nasdaq Junior Biotechnology ETF; Weight 0.13%; Value (USD) $9.72K; Added / first observed 2020-12-31.
ETF Holding It
7 retained portfolio positions. Missing dates and values remain unreported.
| ETF | Fund | Weight | Value (USD) | Added / first observed | Latest report |
|---|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 0.66% | $246.12K | 2022-01-31 | 2026-04-30 |
| GERM | ETFMG Treatments Testing and Advancements ETF | 0.83% | $106.30K | 2020-09-30 | 2023-12-31 |
| GSSC | Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | 0.04% | $382.00K | 2024-08-31 | 2026-02-28 |
| IBBJ | Defiance Nasdaq Junior Biotechnology ETF | 0.13% | $9.72K | 2020-12-31 | 2021-09-30 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% | $24.41K | 2023-07-31 | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.00% | $220.45K | 2018-06-30 | 2026-03-31 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.11% | $555.39K | 2024-10-31 | 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |